186 related articles for article (PubMed ID: 19745552)
1. Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor-gamma gene is associated with metabolic syndrome and surrogate measures of insulin resistance in healthy men: interaction with smoking status.
Tellechea ML; Aranguren F; Pérez MS; Cerrone GE; Frechtel GD; Taverna MJ
Circ J; 2009 Nov; 73(11):2118-24. PubMed ID: 19745552
[TBL] [Abstract][Full Text] [Related]
2. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.
Dongxia L; Qi H; Lisong L; Jincheng G
Circ J; 2008 Apr; 72(4):551-7. PubMed ID: 18362424
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
[TBL] [Abstract][Full Text] [Related]
4. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
[TBL] [Abstract][Full Text] [Related]
5. Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population.
Rooki H; Haerian MS; Azimzadeh P; Mirhafez R; Ebrahimi M; Ferns G; Ghayour-Mobarhan M; Zali MR
Mol Biol Rep; 2014 May; 41(5):3127-33. PubMed ID: 24464185
[TBL] [Abstract][Full Text] [Related]
6. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
7. The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals.
Montagnana M; Fava C; Nilsson PM; Engström G; Hedblad B; Lippi G; Minuz P; Berglund G; Melander O
Diabet Med; 2008 Aug; 25(8):902-8. PubMed ID: 18959602
[TBL] [Abstract][Full Text] [Related]
8. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
9. A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation.
Steinhardt AP; Aranguren F; Tellechea ML; Gómez Rosso LA; Brites FD; Martínez-Larrad MT; Serrano-Ríos M; Frechtel GD; Taverna MJ
Metabolism; 2010 May; 59(5):711-7. PubMed ID: 19922963
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.
Li S; Chen W; Srinivasan SR; Boerwinkle E; Berenson GS;
Diabetes; 2003 May; 52(5):1265-9. PubMed ID: 12716762
[TBL] [Abstract][Full Text] [Related]
11. Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.
Johansson LE; Danielsson P; Norgren S; Marcus C; Ridderstråle M
Int J Pediatr Obes; 2009; 4(2):119-25. PubMed ID: 18645733
[TBL] [Abstract][Full Text] [Related]
12. PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome.
Passaro A; Dalla Nora E; Marcello C; Di Vece F; Morieri ML; Sanz JM; Bosi C; Fellin R; Zuliani G
Cardiovasc Diabetol; 2011 Dec; 10():112. PubMed ID: 22168210
[TBL] [Abstract][Full Text] [Related]
13. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Franks PW; Jablonski KA; Delahanty L; Hanson RL; Kahn SE; Altshuler D; Knowler WC; Florez JC;
Diabetologia; 2007 Dec; 50(12):2451-60. PubMed ID: 17898990
[TBL] [Abstract][Full Text] [Related]
14. Association of Neuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors, Adipokines, and Metabolic Syndrome in Patients with Obesity.
de Luis DA; Izaola O; de la Fuente B; Primo D; Aller R
J Nutrigenet Nutrigenomics; 2016; 9(5-6):213-221. PubMed ID: 27788523
[TBL] [Abstract][Full Text] [Related]
15. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study.
Jaziri R; Lobbens S; Aubert R; Péan F; Lahmidi S; Vaxillaire M; Porchay I; Bellili N; Tichet J; Balkau B; Froguel P; Marre M; Fumeron F;
Diabetes; 2006 Apr; 55(4):1157-62. PubMed ID: 16567542
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma (PPARgamma) Pro12Ala polymorphism and risk for pediatric obesity.
Dedoussis GV; Vidra N; Butler J; Papoutsakis C; Yannakoulia M; Hirschhorn JN; Lyon HN
Clin Chem Lab Med; 2009; 47(9):1047-50. PubMed ID: 19634985
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the rs1801282 single nucleotide polymorphism of the PPARG gene in patients with metabolic syndrome.
Rocha RM; Barra GB; Rosa ÉC; Garcia ÉC; Amato AA; Azevedo MF
Arch Endocrinol Metab; 2015 Aug; 59(4):297-302. PubMed ID: 26331316
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
Kruzliak P; Haley AP; Starcevic JN; Gaspar L; Petrovic D
Cardiovasc Diabetol; 2015 Apr; 14():42. PubMed ID: 25928419
[TBL] [Abstract][Full Text] [Related]
19. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
[TBL] [Abstract][Full Text] [Related]
20. Association between PPAR-γ2 Pro12Ala genotype and insulin resistance is modified by circulating lipids in Mexican children.
Stryjecki C; Peralta-Romero J; Alyass A; Karam-Araujo R; Suarez F; Gomez-Zamudio J; Burguete-Garcia A; Cruz M; Meyre D
Sci Rep; 2016 Apr; 6():24472. PubMed ID: 27075119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
